Barry D. Quart
2020
Compensation breakdown
| Non-Equity Incentive Plan | $364,991 |
|---|---|
| Option Awards | $3,366,895 |
| Salary | $676,838 |
| Stock Awards | $916,995 |
| Other | $21,084 |
| Total | $5,346,803 |
Quart received $3.4M in option awards, accounting for 63% of the total pay in 2020.
Quart also received $365K in non-equity incentive plan, $676.8K in salary, $917K in stock awards and $21.1K in other compensation.
Rankings
In 2020, Barry D. Quart's compensation ranked 2,032nd out of 13,090 executives tracked by ExecPay. In other words, Quart earned more than 84.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,032 out of 13,090 | 85th |
Division Manufacturing | 786 out of 5,621 | 86th |
Major group Chemicals And Allied Products | 282 out of 2,254 | 88th |
Industry group Drugs | 238 out of 1,954 | 88th |
Industry Pharmaceutical Preparations | 167 out of 1,459 | 89th |
Pay ratio
| Barry D. Quart's Pay | $5,346,803 |
|---|---|
| Median Employee's Pay | $363,920 |
| Pay Ratio | 15to 1 |
In 2020, the annual total compensation of Barry D. Quart was $5,346,803.
The annual total compensation of the median employee at Heron Therapeutics was $363,920.
The ratio of Barry D. Quart's pay to the pay of median employee was therefore 15 to one.
Quart's colleagues
We found five more compensation records of executives who worked with Barry D. Quart at Heron Therapeutics in 2020.
2020
John Poyhonen
Heron Therapeutics
President and Chief Commercial Officer
2020
David Szekeres
Heron Therapeutics
Chief Operating Officer
2020
Kimberly Manhard
Heron Therapeutics
Executive Vice President, Drug Development
2020
Lisa Peraza
Heron Therapeutics
Chief Accounting Officer
2020
Robert Hoffman
Heron Therapeutics
Chief Financial Officer
News
April 29, 2024
May 1, 2023
April 25, 2022
April 22, 2021
April 23, 2020